Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin and Norepinephrine in Septic Shock (TERLINOR)
NCT03336814Phase 4Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in septic shock, sponsored by Assistance Publique-Hôpitaux de Marseille. Status: unknown.
02
Drugs
terlipressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03336814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336814.